Selective serotonin reuptake inhibitors and violence: a review of the available evidence
暂无分享,去创建一个
[1] J. Korf,et al. 5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid , 1970, Nature.
[2] M. Åsberg,et al. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.
[3] M. Dubocovich,et al. High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. , 1980, Science.
[4] M. Briley,et al. High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. , 1981, Life sciences.
[5] M. Åsberg,et al. Monoamine metabolites in CSF and suicidal behavior. , 1981, Archives of general psychiatry.
[6] J. Mann,et al. INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS , 1983, The Lancet.
[7] G. Tedeschi,et al. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. , 1983, British journal of clinical pharmacology.
[8] H. Meltzer,et al. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. , 1984, Archives of general psychiatry.
[9] Postmortem serotonergic and adrenergic receptor binding to frontal cortex: correlations with suicide. , 1986, Psychopharmacology bulletin.
[10] M. Linnoila,et al. Suicidal behavior, impulsiveness and serotonin , 1988, Acta psychiatrica Scandinavica.
[11] The benefits and risks of 5-HT uptake inhibitors in depression. , 1988, The British journal of psychiatry. Supplement.
[12] L. Siever,et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.
[13] N. K. Popova,et al. Behavior, adrenocortical activity, and brain monoamines in Norway rats selected for reduced aggressiveness towards man , 1989, Pharmacology Biochemistry and Behavior.
[14] E. Coccaro,et al. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. , 1990, Journal of clinical psychopharmacology.
[15] N. K. Popova,et al. Evidence for the involvement of central serotonin in mechanism of domestication of silver foxes , 1991, Pharmacology Biochemistry and Behavior.
[16] C. Beasley,et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. , 1991, BMJ.
[17] E. Coccaro,et al. Fluoxetine Not Associated With Increased Violence or Aggression in Controlled Clinical Trials , 1992 .
[18] C. Beasley,et al. Fluoxetine and suicide : a meta-analysis of controlled trials of treatment for depression , 1992 .
[19] R. Kahn,et al. Functional interrelationship of serotonin and norepinephrine: Cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects , 1992, Psychiatry Research.
[20] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[21] M. Fava,et al. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment. , 1993, The American journal of psychiatry.
[22] J. Fawcett,et al. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders. , 1993, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[23] G. Enas,et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. , 1994, Journal of clinical psychopharmacology.
[24] L. Siever,et al. Familial correlates of reduced central serotonergic system function in patients with personality disorders. , 1994, Archives of general psychiatry.
[25] C. Sánchez,et al. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. , 1994, European journal of pharmacology.
[26] M. Linnoila,et al. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. , 1994, The American journal of psychiatry.
[27] R. Pies,et al. Self-injurious behavior: pathophysiology and implications for treatment. , 1995, The Journal of clinical psychiatry.
[28] R. Hen,et al. Serotonin receptors and animal models of aggressive behavior. , 1995, Pharmacopsychiatry.
[29] H. Jick,et al. Antidepressants and suicide , 1995, BMJ.
[30] M. Keller,et al. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. , 1996, The Journal of clinical psychiatry.
[31] L. Siever,et al. Impulsivity and serotonergic function in compulsive personality disorder. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[32] M. Fava,et al. Fluoxetine treatment of anger attacks: a replication study. , 1996, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[33] Fluoxetine in the treatment of anger: an open clinical trial. , 1996, The Journal of clinical psychiatry.
[34] S. Kasper,et al. Risk of suicide in depression and its implication for psychopharmacological treatment , 1996, International clinical psychopharmacology.
[35] M. Fava,et al. Hostility changes following antidepressant treatment: relationship to stress and negative thinking. , 1996, Journal of psychiatric research.
[36] C. McDougle,et al. Neurobiology of Tryptophan Depletion in Depression: Effects of m-Chlorophenylpiperazine (mCPP) , 1997, Neuropsychopharmacology.
[37] L. Siever,et al. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness , 1997, Psychiatry Research.
[38] E. Coccaro,et al. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. , 1997, Archives of general psychiatry.
[39] M. Linnoila,et al. Low Central Nervous System Serotonergic Activity Is Traitlike and Correlates with Impulsive Behavior , 1997, Annals of the New York Academy of Sciences.
[40] R. Mann,et al. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies , 1997, Pharmacoepidemiology and drug safety.
[41] C. Caley,et al. Extrapyramidal Reactions and the Selective Serotonin-Reuptake Inhibitors , 1997, The Annals of pharmacotherapy.
[42] R. Saunders,et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. , 1998, The American journal of psychiatry.
[43] A. Papassotiropoulos,et al. Upregulation of the Platelet Serotonin2A Receptor and Low Blood Serotonin in Suicidal Psychiatric Patients , 1998, Neuropsychobiology.
[44] H. V. van Praag. Anxiety and increased aggression as pacemakers of depression. , 1998, Acta psychiatrica Scandinavica. Supplementum.
[45] L. Lynd,et al. Selective Serotonin-Reuptake Inhibitor–Induced Movement Disorders , 1998, The Annals of pharmacotherapy.
[46] M. Fava,et al. Anger attacks in depressed outpatients and their response to fluoxetine , 1998, European Psychiatry.
[47] L. Siever,et al. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts , 1998, Psychiatry Research.
[48] N. K. Popova,et al. Specific [3H]8-OH-DPAT Binding in Brain Regions of Rats Genetically Predisposed to Various Defense Behavior Strategies , 1998, Pharmacology Biochemistry and Behavior.
[49] D. Healy,et al. Suicide in the course of the treatment of depression , 1999, Journal of psychopharmacology.
[50] W. Coryell,et al. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. , 1999, The American journal of psychiatry.
[51] R. Hen,et al. Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.
[52] J. Mann,et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. , 2000, The American journal of psychiatry.